Monie R D, Hunter A M, Rocchiccioli K, White J, Campbell I A, Kilpatrick G S
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):571-3. doi: 10.1136/bmj.284.6315.571.
In routine clinical practice 20% of patients with pulmonary tuberculosis were treated with the regimen recommended by the British Thoracic Association after the British trial of short-course chemotherapy. Despite the use of several regimens that could be considered inadequate, no patients from the survey within south and west Wales appears to have relapsed yet. Deaths from pulmonary tuberculosis continue at the same rate as 10 years ago. Patient default remains a difficult problem even with modern, less toxic, short-course regimens.
在常规临床实践中,20%的肺结核患者采用了英国胸科学会在英国短程化疗试验后推荐的治疗方案。尽管使用了几种可能被认为不充分的治疗方案,但威尔士南部和西部调查中的患者似乎尚未出现复发情况。肺结核导致的死亡人数仍维持在与10年前相同的水平。即便采用现代的、毒性较小的短程治疗方案,患者中途放弃治疗仍是一个难题。